CTr increases proliferation of estrogen-dependent breast tumor cells, binds with a strong affinity for the estrogen receptor-alpha (ERa), and activates the expression of the estrogen (E2)-dependent gene [158,195]. Here, ESR1 is linked to breast neoplasm.